During the past decade, ReumaClinic conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ReumaClinic" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ReumaClinic" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "nv Roche sa" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ReumaClinic" are "Rheumatoid Arthritis" (9 trials), "Arthritis, Psoriatic" (2 trials), "Psoriatic Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "ReumaClinic" in a lesser frequency.

Most popular intervention types in "ReumaClinic" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "Filgotinib" (2 trials), "Methotrexate" (2 trials) and "Tocilizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "ReumaClinic" are 15 trials for "All" genders.

Currently, there are NaN active trials in "ReumaClinic". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in ReumaClinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ReumaClinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".